These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Wiener ES; Anderson JR; Ojimba JI; Lobe TE; Paidas C; Andrassy RJ; Raney RB; Qualman SJ; Donaldson SS; Maurer HM; Link MP; Crist WM; Grier HE Semin Pediatr Surg; 2001 Aug; 10(3):146-52. PubMed ID: 11481652 [TBL] [Abstract][Full Text] [Related]
7. The management of paratesticular rhabdomyosarcoma: a single institutional experience with 44 consecutive children. Ferrari A; Casanova M; Massimino M; Luksch R; Piva L; Fossati-Bellani F J Urol; 1998 Mar; 159(3):1031-4. PubMed ID: 9474226 [TBL] [Abstract][Full Text] [Related]
8. Paratesticular rhabdomyosarcoma in childhood. Raney RB; Hays DM; Lawrence W; Soule EH; Tefft M; Donaldson MH Cancer; 1978 Aug; 42(2):729-36. PubMed ID: 354776 [TBL] [Abstract][Full Text] [Related]
9. Delayed Return of Ejaculatory Function in Adolescent Males Treated With Retroperitoneal Lymph Node Dissection and Adjuvant Therapy for Paratesticular Rhabdomyosarcoma. T Rague J; Varda BK; Wagner AA; Lee RS Urology; 2019 Feb; 124():254-256. PubMed ID: 30366047 [TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal lymph node staging in paratesticular rhabdomyosarcoma-are we meeting expectations? Hamilton EC; Miller CC; Joseph M; Huh WW; Hayes-Jordan AA; Austin MT J Surg Res; 2018 Apr; 224():44-49. PubMed ID: 29506850 [TBL] [Abstract][Full Text] [Related]
11. Retroperitoneal lymph node dissection in patients with high risk testicular cancer. Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227 [TBL] [Abstract][Full Text] [Related]
15. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience. Hyams ES; Pierorazio P; Proteek O; Sroka M; Kavoussi LR; Allaf ME J Urol; 2012 Feb; 187(2):487-92. PubMed ID: 22177913 [TBL] [Abstract][Full Text] [Related]
16. Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors. Mano R; Becerra MF; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Feldman DR; Sheinfeld J J Urol; 2017 Feb; 197(2):391-397. PubMed ID: 27720783 [TBL] [Abstract][Full Text] [Related]
17. Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients. Cheney SM; Andrews PE; Leibovich BC; Castle EP BJU Int; 2015 Jan; 115(1):114-20. PubMed ID: 24825773 [TBL] [Abstract][Full Text] [Related]
18. Surgical resection of a massive residual retroperitoneal mass after chemotherapy for a paratesticular rhabdomyosarcoma: a case report. Chalouati T; Ghalleb M; Jallali A; Slimane M; Sahraoui G; Ben Hassouna J; Chargui R; Rahal K J Med Case Rep; 2022 Dec; 16(1):476. PubMed ID: 36550579 [TBL] [Abstract][Full Text] [Related]
19. Robotic retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma in adolescents: a case series. Clark CN; Smith J; Fuchs ME; Ching CB; DaJusta DG J Robot Surg; 2023 Dec; 17(6):3045-3048. PubMed ID: 37971637 [TBL] [Abstract][Full Text] [Related]